Platelet-rich plasma, or PRP, grew out of research into blood components and their role in clotting and tissue repair.
Its development connects several medical fields. However, a long history of studying platelets does not mean every treatment now marketed as PRP has the same evidence or expected results.
Start with the role of platelets
Platelets are small cell fragments that help the body respond to blood-vessel injury. They participate in clot formation and release signaling molecules involved in healing.
Understanding those functions led researchers to investigate whether concentrated platelet preparations could be useful in selected clinical situations.
The distinction matters: a platelet’s normal biological role provides a rationale for research, not automatic proof of a treatment benefit.
Blood components and regenerative treatment
Platelet concentrates used in transfusion medicine and PRP preparations used in tissue-repair research are related through their blood-derived components, but they serve different purposes.
They should not be described as one identical treatment that simply moved from one specialty to another.
Collection, processing, composition, and intended use all influence what a preparation actually contains and how it is administered.
How research expanded
Researchers and clinicians have explored platelet preparations in areas including oral surgery, musculoskeletal care, wound management, dermatology, and aesthetics.
The evidence differs by condition and application. A benefit reported for one type of wound or procedure cannot automatically establish effectiveness for facial wrinkles, under-eye concerns, or hair thinning.
Even within a single specialty, outcomes depend on the specific diagnosis and protocol.
Why PRP is not one standardized product
PRP generally refers to plasma with a higher platelet concentration than the starting blood sample. There is no single concentration or preparation method shared by every system.
Products can differ in platelet numbers, white blood cell content, red blood cell contamination, additives, and activation methods.
That variability is one reason studies can be difficult to compare. Calling a preparation PRP does not tell us everything needed to predict its clinical behavior.
Where PRF and PRFM fit
Platelet-rich fibrin and platelet-rich fibrin matrix involve different approaches to processing blood and forming a fibrin network.
They are often presented as successive generations of treatment. However, being newer or having a different structure does not establish universal clinical superiority.
Each preparation needs evidence relevant to the condition and method being proposed.
What this history means for patients
The useful question is not simply how long platelet treatments have existed. It is whether the particular preparation and procedure have adequate evidence for your concern.
Ask what is being used, what improvement is realistic, how many sessions are proposed, and what risks and alternatives deserve consideration.
PRP’s history explains why it continues to attract research interest. Decisions about treatment should rest on the evidence for the specific application rather than its reputation as “natural” or “regenerative.”
Updated October 23, 2026.